000 | 01993 a2200541 4500 | ||
---|---|---|---|
005 | 20250514231635.0 | ||
264 | 0 | _c20060130 | |
008 | 200601s 0 0 eng d | ||
022 | _a1524-4539 | ||
024 | 7 |
_a10.1161/CIRCULATIONAHA.104.481515 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLeong-Poi, Howard | |
245 | 0 | 0 |
_aAssessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. _h[electronic resource] |
260 |
_bCirculation _cJun 2005 |
||
300 |
_a3248-54 p. _bdigital |
||
500 | _aPublication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aArteries _xdiagnostic imaging |
650 | 0 | 4 |
_aBiomarkers _xanalysis |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aContrast Media |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 |
_aEndothelium, Vascular _xchemistry |
650 | 0 | 4 |
_aFibroblast Growth Factor 2 _xpharmacology |
650 | 0 | 4 | _aHindlimb |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntegrin alpha5beta1 _xanalysis |
650 | 0 | 4 |
_aIntegrin alphaV _xanalysis |
650 | 0 | 4 |
_aIntegrins _xanalysis |
650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
650 | 0 | 4 |
_aIschemia _xdrug therapy |
650 | 0 | 4 | _aMicrobubbles |
650 | 0 | 4 |
_aNeovascularization, Physiologic _xdrug effects |
650 | 0 | 4 | _aPeptides |
650 | 0 | 4 |
_aPeripheral Vascular Diseases _xdrug therapy |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUltrasonography _xmethods |
700 | 1 | _aChristiansen, Jonathan | |
700 | 1 | _aHeppner, Peter | |
700 | 1 | _aLewis, Christopher W | |
700 | 1 | _aKlibanov, Alexander L | |
700 | 1 | _aKaul, Sanjiv | |
700 | 1 | _aLindner, Jonathan R | |
773 | 0 |
_tCirculation _gvol. 111 _gno. 24 _gp. 3248-54 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCULATIONAHA.104.481515 _zAvailable from publisher's website |
999 |
_c15615307 _d15615307 |